Mindfulness and Acceptance Group Therapy for Substance Use

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by The University of Tennessee Knoxville
Sponsor:
Information provided by (Responsible Party):
The University of Tennessee Knoxville
ClinicalTrials.gov Identifier:
NCT01751542
First received: December 13, 2012
Last updated: NA
Last verified: December 2012
History: No changes posted
  Purpose

Randomized clinical trial comparing standard residential substance abuse treatment to standard residential treatment plus Mindfulness and Acceptance Group Therapy for substance use.


Condition Intervention Phase
Substance Use Disorder
Behavioral: Mindfulness + Residential Treatment
Behavioral: Residential treatment alone
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Mindfulness and Acceptance Group Therapy for Substance Use

Further study details as provided by The University of Tennessee Knoxville:

Primary Outcome Measures:
  • Substance use after discharge from treatment [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: August 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness + residential treatment
Mindfulness and Acceptance Group Therapy + residential treatment
Behavioral: Mindfulness + Residential Treatment
Active Comparator: Residential Treatment
Residential treatment alone
Behavioral: Residential treatment alone

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • participating in inpatient substance use treatment at treatment facility

Exclusion Criteria:

  • psychosis and mental impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01751542

Locations
United States, Tennessee
University of Tenneessee & Cornerstone of Recovery Recruiting
Knoxville, Tennessee, United States, 37996
Contact: Gregory Stuart, PhD    865-974-3358      
Principal Investigator: Gregory L Stuart, PhD         
Principal Investigator: Ryan Shorey, MA         
Sponsors and Collaborators
The University of Tennessee Knoxville
  More Information

No publications provided

Responsible Party: The University of Tennessee Knoxville
ClinicalTrials.gov Identifier: NCT01751542     History of Changes
Other Study ID Numbers: 8888-B
Study First Received: December 13, 2012
Last Updated: December 13, 2012
Health Authority: United States: University of Tennessee-Knoxville IRB

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on October 23, 2014